Back to search
FDAFDA · Food and drugs·Recall number D-0225-2024

Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598

Published December 6, 2023 · Recall initiated: October 20, 2023

Summary

FDA records drug Class I recall D-0225-2024, published December 6, 2023 and initiated October 20, 2023. Recalling firm: Botanical Be; Status: Ongoing; Lot: All lots, exp 10/20/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Botanical Be
Distributor
USA Nationwide
Lot
All lots, exp 10/20/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598 recalled?

Yes. FDA published recall D-0225-2024 on December 6, 2023. Reported hazard: Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone